NCT05905900View on ClinicalTrials.gov

Emergent Prep for IV Dye in Acute Stroke Patients With Allergy

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 18, 2019

Study Completion Date

June 30, 2023

Conditions
StrokeDye Allergy
Interventions
COMBINATION_PRODUCT

Emergent IV Dye Preparation

Diphenhydramine 50 mg IV once, famotidine 20 mg IV once, and dexamethasone 10 mg IV once

Trial Locations (1)

Unknown

Philadelphia

Sponsors
All Listed Sponsors
collaborator

Drexel University College of Medicine

OTHER

lead

Global Neurosciences Institute

OTHER